Compounds > azacitidine

azacitidine and Carcinoma, Papillary

azacitidine has been researched along with Carcinoma, Papillary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, YM; Gu, J; Ji, QH; Liao, T; Qu, N; Shi, RL; Sun, GH; Wang, Y; Wang, YJ; Wei, WJ; Wen, D; Yu, J; Zhang, L; Zhang, YS; Zhao, YX; Zhu, YX1
Huang, H; Huang, Z; Lin, J; Lin, X; Qiu, J; Shi, B; Wang, C; Wei, X; Wu, W; Zhang, L1
Katoh, R; Kawasaki, T; Kobayashi, M; Kondo, T; Ma, D; Mochizuki, K; Nakamura, N; Nakazawa, T; Niu, D; Yamane, T1
Dong, X; Korch, C; Meinkoth, JL1
Hayashi, Y; Imai, T; Kikumori, T; Kiuchi, T; Kurebayashi, J; Murata, Y; Sassa, M; Watanabe, R1
Byun, DW; Chun, SW; Jung, CH; Kang, SG; Kim, BY; Kim, CH; Kim, SJ; Kim, YJ; Ko, HJ; Mok, JO; Park, HK; Suh, KI; Yoo, MH1
Jiang, P; Mouri, H; Ohtsubo, K; Okada, G; Sawabu, N; Tsuchiyama, T; Watanabe, H; Yao, F1
Ain, KB; Marcinek, R; Venkataraman, GM; Yatin, M1

Other Studies

8 other study(ies) available for azacitidine and Carcinoma, Papillary

ArticleYear
Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Oncology reports, 2018, Volume: 39, Issue:1

    Topics: Apoptosis; Azacitidine; Carcinoma, Papillary; Cell Line, Tumor; Cell Movement; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Male; Mutation; Neoplasm Invasiveness; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Transcription Factors

2018
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: Adult; Apoptosis; Azacitidine; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Transcription Factors; Male; Middle Aged; Promoter Regions, Genetic; Sirtuin 1; Thyroid Neoplasms

2016
Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas.
    Laboratory investigation; a journal of technical methods and pathology, 2009, Volume: 89, Issue:7

    Topics: Azacitidine; Base Sequence; Carcinoma, Papillary; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Decitabine; DNA Methylation; DNA Primers; Epigenesis, Genetic; Gene Expression Profiling; Gene Silencing; Histones; Humans; Hydroxamic Acids; Nuclear Proteins; RNA, Messenger; RNA, Neoplasm; Thyroid Gland; Thyroid Neoplasms; Thyroid Nuclear Factor 1; Transcription Factors

2009
Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.
    Endocrine-related cancer, 2011, Volume: 18, Issue:3

    Topics: Adenocarcinoma, Follicular; Azacitidine; Butyrates; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasm Proteins; rap GTP-Binding Proteins; rap1 GTP-Binding Proteins; RNA, Small Interfering; Thyroid Neoplasms; Up-Regulation

2011
Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:5

    Topics: Adult; Aged; Apoptosis Regulatory Proteins; Azacitidine; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Thyroid Cancer, Papillary; Thyroid Neoplasms; Trans-Activators; Transcription Factors

2011
DNA methylation of RUNX3 in papillary thyroid cancer.
    The Korean journal of internal medicine, 2012, Volume: 27, Issue:4

    Topics: Azacitidine; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Core Binding Factor Alpha 3 Subunit; Decitabine; DNA Methylation; Gene Expression; Humans; Thyroid Cancer, Papillary; Thyroid Neoplasms

2012
Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Cancer science, 2006, Volume: 97, Issue:11

    Topics: Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Male; Middle Aged; Pancreatic Juice; Pancreatic Neoplasms; Pancreatitis, Chronic; Polymerase Chain Reaction; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm

2006
Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:7

    Topics: Adenoma; Antimetabolites, Antineoplastic; Azacitidine; Butyrates; Carcinoma, Papillary; Carrier Proteins; DNA; DNA Methylation; Gene Expression; Humans; Iodides; Membrane Proteins; Promoter Regions, Genetic; RNA, Messenger; Symporters; Thyroid Neoplasms; Transcription, Genetic; Tumor Cells, Cultured

1999